Company Score

Industry Pharmaceuticals, Biotechnology & Life Sciences
Country United States
Year Added 2018
Impact Ratings 343
Impact Notes 15
SDG Covered 5 out of 17

AbbVie is an American publicly-traded biopharmaceutical company, it originated as a spin-off of Abbott Laboratories, with AbbVie focusing on research-based pharmaceutical manufacturing. According to the Wall Street Journal as of January 2016 ibrutinib, a speciality drug, cost US$116,600 to $155,400 a year wholesale in the United States. In spite of discounts and medical insurance, the prohibitive price causes some patients to not fill their prescriptions. AbbVie estimates global sales of the drug at $1 billion in 2016 and $5 billion in 2020.

Read about AbbVie and its impact below.

Impact notes

Responsible Consumption and Production

US’s top pharma company, Abbvie’s hazardous waste generation is drastically rising

Profile Kanak Gupta
Icon time Fri Dec 18th, 2020 at 9:10am

About 100,000 tons of pharmaceutical products are manufactured worldwide every year1. These products create a lot of waste, which is harmful to the environment1. As per WHO, 85% of pharmaceutical waste can be categorized as non-hazardous and 15% as hazardous2.

Climate Action

Abbvie’s GHG emissions (scope 1&2) were 564,000 metric tonnes of CO2e in 2019

Profile Kanak Gupta
Icon time Wed Dec 16th, 2020 at 5:13pm

Every year, over 50 billion tonnes of GHGs (CO2e) is emitted across the world3. Rapidly rising greenhouse gas (GHG) emissions are responsible for trapping heat in the atmosphere, which results in global warming1Consequences of global warming include rising sea levels, melting of the glaciers, health problems, disruption in the food supply, and others1.

Good Health and Well-being

Abbvie’s multiple sclerosis drug, Zinbryta, found to be causing dangerous side effects in patients

Profile Kanak Gupta
Icon time Tue Dec 15th, 2020 at 6:43am

As per the 2019 World Drug Report, 35 million people suffered from drug use disorders1Annually, 200,000 people die due to prescription drugs' adverse impacts2. Pharmaceutical treatments help individuals to live longer and better lives. At the same time, the pharma industry has a duty to the public to make safe products. 

Responsible Consumption and Production

AbbVie reduced its absolute water usage by 11%, but its absolute water withdrawal increased by 4% in 2018, as compared to 2015

Profile Surbhi Kohli
Icon time Tue Jul 28th, 2020 at 5:29pm

According to the World Health Organization (WHO), 785 million people worldwide do not have access to drinking water1. An estimated 4.5 billion global population live within 50 km of an impaired water resource2. The pharmaceutical industry requires high-quality water to meet its production requirements4.

Climate Action

AbbVie achieves 13 per cent reduction in absolute carbon emissions through technology and innovation

Profile DP
Icon time Mon May 18th, 2020 at 5:23am

According to the World Health Organization1, climate change will have an overwhelmingly negative effect on human health globally. With the increase in deadly tropical and weather-related diseases, an increase in the demand for drugs and vaccines is expected. As this opens market for the pharma industries, it is important for the industry to grow their businesses sustainably by reducing their carbon emission from manufacturing sites.